Purpose: Gadolinium deposition in dentate nucleus (DN) has been reported after serial administration of gadoliniumbased contrast agents (GBCAs). Gadolinium complexes have paramagnetic properties; therefore, we evaluated susceptibility changes of gadolinium deposition in DN using quantitative susceptibility mapping (QSM) for patients after serial administration of GBCAs. Materials and Methods: In all, 48 patients with brain tumors, who had had serial GBCA administrations (GBCA group), and 48 healthy volunteers without any history of GBCA administrations (non-GBCA group) were enrolled in this study. Susceptibility values in DN on QSM and DN-to-cerebellum signal intensity ratios on unenhanced T 1 -weighted images (T 1 ratios) on 3T were analyzed. The relationship between the number of times of GBCA administrations and susceptibility values or T 1 ratios were evaluated in the GBCA group. Results: Susceptibility values at DN in the GBCA group were 0.107 6 0.029 ppm, and significantly higher than those of the non-GBCA group (0.079 6 0.025 ppm) (P < 0.0001). T 1 ratios in DN of the GBCA group were 1.059 6 0.070, and also significantly higher than that of the non-GBCA group (0.993 6 0.016) (P < 0.0001). Spearman rank correlation coefficients between susceptibility values and the number of times of linear GBCA administration showed a modest significant correlation (q 5 0.45, P 5 0.0015). There was good correlation between T 1 ratios and the number of times of linear GBCA administration, as reported previously (q 5 0.76, P < 0.0001). Conclusion: Susceptibility values on QSM in DN of the GBCA group, after serial administration of GBCAs, were significantly higher than those of the non-GBCA group. Evidence level: 3
G adolinium-based contrast agents (GBCAs) have been widely used for contrast-material-enhanced magnetic resonance imaging (MRI). It is well known that blood-brain barrier (BBB) failure leads to leakage of the GBCAs and high signal intensity on T 1 -weighted images in the central nervous system (CNS). GBCAs have been frequently used for evaluation of CNS diseases such as brain tumors and demyelinating diseases. In addition to the discovery of nephrogenic systemic fibrosis (NSF) due to free gadolinium deposition to cutaneous tissues, gadolinium accumulation in the dentate nucleus (DN) has gained attention after recent reports by Kanda et al, [1] [2] [3] Errante et al, 4 McDonald et al, however, susceptibility changes on quantitative susceptibility mapping (QSM) due to the paramagnetic effect of gadolinium may provide a more quantitative assessment. Magnetic susceptibility is conventionally evaluated on T Ã 2 -weighted imaging qualitatively on MRI, 10 but QSM is a robust technique due to its direct measurement of voxelwise tissue magnetic susceptibility from phase images. [11] [12] [13] [14] [15] Based on recent studies, QSM can provide in vivo quantitative susceptibility values. 16, 17 QSM has been applied to study hemorrhages, 18, 19 multiple sclerosis, 20, 21 and neurodegenerative diseases such as Alzheimer's disease 22 and Parkinson's disease. 23, 24 In these diseases, iron accumulation or demyelination is supposed to occur in the brain, which consequently increase magnetic susceptibility values. [18] [19] [20] [21] 25 In this study we hypothesized that serial use of GBCA will increase magnetic susceptibility values in DN of humans on QSM images. Serial use of GBCA was performed for limited purposes such as follow-up studies of patients with brain tumors and multiple sclerosis. Therefore, we retrospectively investigated susceptibility values in DN of brain tumor patients who had serial GBCA administration in comparison with healthy volunteers who had no history of GBCA administration
Materials and Methods

Subjects
This single-center, retrospective observational study was performed after Institutional Review Board (IRB) approval, with waiver of the informed consent requirement. We assessed 53 consecutive patients with brain tumors since April 2014, whose original phase images of 3D gradient-echo sequence were archived. Five patients were excluded because of whole brain radiotherapy, or tumor-selective radiation therapy that included the DN within the radiation field, renal dysfunction. In total, 48 patients were finally enrolled in this study (the GBCA group). Most patients underwent several MRI scans with GBCA administration (linear and/or macrocyclic GBCA). The number of GBCA administrations including linear and macrocyclic GBCA were abstracted from medical charts. GBCA of 0.1 mmol per kg of the patient's body weight was injected for each scan. Forty-eight healthy volunteers without any history of GBCA administration were recruited as a comparison group for QSM, with IRB approval and written informed consent (the non-GBCA group).
Image Acquisition
All the subjects had MRI examinations on 3T MR scanners (Magnetom Skyra or Trio, Siemens, Erlangen, Germany) with a 32-channel head coil. ; resolution, 0.9 3 0.9 3 0.9 mm). 3D sagittal T 1 -weighted images were reformatted to axial planes parallel to the axial images.
QSM Analysis
QSM calculation was conducted from the magnitude and phase images of the gradient echo images using STI Suite v. 2.10 (http:// people.duke.edu/~cl160/). We first performed phase unwrapping and background phase removal using the sophisticated harmonic artifact reduction for phase data with a variable radius of the spherical kernel at the brain boundary (V-SHARP method). 26, 27 During this process, binary brain masks, created from the magnitude image with the BET tool, were applied to facilitate the removal of background phase. 28 After background phase removal, a susceptibility map was reconstructed from the resulting local tissue phase image by solving an inverse problem using the algorithm for sparse linear equations and sparse least squares (iLSQR method).
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ROI Analysis
A region of interest (ROI) study was performed by two boardcertified neuroradiologists (T.H., 8 years of experience, Y.F., 18 years of experience) by manual placement of ROIs of DN and white matter in the right cerebellar hemisphere on both T 1 -weigheted images and QSM images using ImageJ software (National Institutes of Health, Bethesda, MD) ( Fig. 1 ). 2,3 ROI placement was agreed on by consensus, and ROI measurement was conducted once. In general, QSM images delineate DN very well in both groups; however, it is difficult to recognize DN on T 1 -weighted images for the non-GBCA group. Therefore, ROIs were placed by referring to QSM images. The mean of the susceptibility values of DN were measured and T 1 ratios were defined as follows: mean values of DN divided by those of the cerebellar white matter on T 1 -weighted images.
Statistics
We performed an unpaired t-test with Welch correlation to assess the difference of susceptibility values and T 1 ratios of DN between: 1) the GBCA group (patients) vs. the non-GBCA group (healthy volunteers); 2) only macrocyclic GBCA administration in the GBCA group vs. the non-GBCA group; 3) only linear GBCA or both linear and macrocyclic GBCA administrations in the GBCA group vs. the non-GBCA group. Nonparametric Spearman rank correlation coefficient was analyzed for: i) susceptibility values or T 1 ratios vs. the number of times of linear GBCA administration; ii) susceptibility values and T 1 ratios in the non-GBCA group vs. subjects' age. All the statistical analyses were conducted using MedCalc v. 13.3 (Ostend, Belgium). P < 0.05 indicated a statistically significant difference. In the first place, multiple regression analysis was conducted with the following variables concerning the effect on the susceptibility values: the times of linear GBCA administrations, mean intervals, median intervals, last intervals, all periods. None of these variables had any significant effect on susceptibility values except the times of the linear GBCA administrations (P 5 0.0066); therefore, in the next step we adopted the Spearman rank correlation coefficient between susceptibility values and the number of times of linear GBCA administration.
Results
Subjects
The subjects' characteristics are shown in Table 1 . The age distribution between the GBCA group and the non-GBCA group was not significantly different (P 5 0.382). No patient received double-dose or triple-dose GBCA administration. The median number of times of GBCA administration among the GBCA group was 9.5 (4.75-21, 25 th -75 th percentile, 1-62; range of the number). Both linear type and macrocyclic type GBCA had been administered to the same patients with long-term follow-up because linear GBCA had been used for most of gadolinium-enhanced studies before the NSF problem was publicly known. The median number of times of linear type GBCA administration was 5 (1-12.5, 0-48) (n 5 41), and that of macrocyclic GBCAs administration was 4 (1-7, 0-39) (n 5 43). Among them, the number of macrocyclic GBCAs administration without any linear GBCA administration was 1 (1-2, 1-7) (n 5 7).
Susceptibility Value and T 1 Ratio Between GBCA and the Non-GBCA Group
The susceptibility values at DN in the GBCA group were significantly higher than those of the non-GBCA group (mean 6 SD, GBCA group, 0.107 6 0.029 ppm; non-GBCA group, 0.079 6 0.025 ppm, P < 0.0001) (Fig. 2) . T 1 ratios at DN in the GBCA group were also significantly higher than that of the non-GBCA group (GBCA group, 1.059 6 0.070; non-GBCA group, 0.993 6 0.016, P < 0.0001) (Fig. 3) .
Susceptibility Values and T 1 Ratios for Linear GBCA Administration
Among all the subjects of the GBCA group and the non-GBCA group (n 5 48), the Spearman rank correlation coefficient between susceptibility values and the number of times of linear GBCA administration showed a modest but Median (25th-75th percentile). The radiation field did not cover the cerebellum in radiation therapy.
FIGURE 2: Graph of the mean susceptibility value difference between the GBCA group, who had had serial GBCA administrations, and the non-GBCA group, who had had no GBCA administration. Susceptibility values at DN in the GBCA group were significantly higher than those in the non-GBCA group (P < 0.0001). Error bars represent the 95% confidence intervals.
FIGURE 3: Graph of the mean T 1 ratio (signal ratio of dentate nucleus / cerebellum cortex on T 1 -weighted images) differences between the GBCA group and the non-GBCA group. T 1 ratios in the GBCA group were also significantly higher than those in the non-GBCA group (P < 0.0001). Error bars represent the 95% confidence intervals.
significant correlation (q 5 0.45, P 5 0.0015) (Fig. 4) . On the other hand, there was a good correlation between T 1 ratios and the number of times of linear GBCA administration (q 5 0.76, P < 0.0001) (Fig. 5) . Spearman rank correlation coefficient analysis between susceptibility values and T 1 ratios showed weak correlation (q 5 0.53, P 5 0.0001) (Fig. 6) .
Susceptibility Values and T 1 Ratios for Macrocyclic GBCA Administration and Linear GBCA Administration
The mean susceptibility values in the DN of the patients who had only macrocyclic GBCA administration (n 5 7) was 0.087 6 0.019 ppm; the mean T 1 ratio was 0.979 6 0.031. There was no significant difference of susceptibility values (P 5 0.348) or T 1 ratios (P 5 0.745) between macrocyclic GBCA-only group and the non-GBCA group. The mean susceptibility value in the DN of those who had only linear GBCA (n 5 5) or both linear and macrocyclic GBCA administration (n 5 36) was 0.111 6 0.029 ppm; the mean T 1 ratio was 1.070 6 0.069. There was a significant difference of susceptibility values (P < 0.0001) and T 1 ratio (P < 0.0001) between the linear or both linear and macrocyclic GBCA group and non-GBCA group.
Susceptibility Values and T 1 Ratios in the Non-GBCA Group in Comparison With Subjects' Age
Susceptibility values had a weak correlation between subjects' age in the non-GBCA group (q 5 0.38, P 5 0.0074), and T 1 ratios also had a weak negative correlation (q 5 -0.331, P 5 0.0217).
Discusson
Our analyses have shown that susceptibility values in DN of the GBCA group (tumor patients group after serial GBCA administrations) were significantly higher than those of the non-GBCA group (healthy controls) and T 1 ratios of the GBCA group were significantly higher than those of the non-GBCA group. In the current study we focused on the serial injection of GBCA and gadolinium deposition in DN as indicated by previous reports. 1, 5 The results of T 1 ratios are consistent with previous reports 1, 5 and we again confirmed T 1 hyperintensity due to gadolinium deposition after serial GBCA administration. DN is known to have rich iron content, 29 and high susceptibility in DN has been reported. 30 Gadolinium is a strong paramagnetic substance with a molar susceptibility of 325 ppmÁL/mol. Therefore, theoretically susceptibility values in DN should elevate when the T 1 ratios shows gadolinium deposition in DN after serial GBCA administrations. The results of higher susceptibility values in DN of the GBCA group than the non-GBCA group supports our initial hypothesis that QSM can be a biomarker of gadolinium deposition in vivo in addition to T 1 -weghted images. In a recent study, macrocyclic GBCA showed less or no abnormal deposition in the DN than linear GBCA, which supported that macrocyclic GBCA has excellent chemical stability without dissociation of free gadolinium. 3 In this study, the number of the GBCA group with only macrocyclic GBCA was quite small, but the susceptibility values were close to those of the non-GBCA group and had no significant difference. On the contrary, the susceptibility values of the GBCA group, with previous linear GBCA administration with/without macrocyclic GBCA administration, were significantly higher than those of the non-GBCA group. On T 1 -weighted images, previous reports have shown a strong association between the hyperintensity in the DN and linear GBCA 3 ; our results reinforce the previous result. Gadolinium deposition in DN has been correlated with the number of times of linear GBCA administration, as reported in the literature. [1] [2] [3] 5 Our study showed that susceptibility values in DN correlated less well with the number of times of linear GBCA administration than T 1 ratios did. One reason for the weaker correlation between susceptibility and the number of times of linear GBCA administration is the endogenous substances causing susceptibility changes in DN that cause less T 1 shortening and vary in individuals; in addition, the normal range of the susceptibility values in DN is quite wide and can be affected by the variation of age in the group. Relaxivities (R1 and R2) of GBCA is 3-5 L/mM/s and the T 1 relaxation time of brain tissue is relatively long, in contrast to the T 2 relaxation time of brain tissue; therefore, deposition of gadolinium will effectively cause a T 1 shortening effect. In spite of the predominance of a T 1 shortening effect, significant susceptibility changes associated with putative gadolinium deposition in the GBCA group were demonstrated in this study. Moreover, the QSM showed wider variation in DN. Therefore, this wider variation of susceptibility values in DN could be the reason for the weaker correlation between susceptibility values and the number of times of GBCA administration. In a prior postmortem study, iron content varied with age in the globus pallidus, caudate nucleus, and putamen 29 and on MR images DN showed various signal intensity, 31 specifically, susceptibility values of DN also could change due to iron deposition with aging, and this has been reported in a recent study using QSM. 32, 33 In our study, the result of the Spearman rank correlation coefficient between susceptibility values in DN and subjects' age showed a weak but significant correlation that was consistent with previous studies. 32, 33 Nevertheless, in a short time window (eg, 2-3 years) when age-related changes are negligible, QSM provides a means to quantitatively monitor GBCA deposition in DN longitudinally because of its quantitative nature and high sensitivity to GBCA. This retrospective study of QSM and gadolinium deposition in DN had several limitations. First, to assess the deposition of gadolinium in DN correctly, a sequential prospective study would be needed. In this study, consecutive evaluation of susceptibility values and T 1 ratios was not performed. Macrocyclic GBCA was reported to be low gadolinium deposition in contrast to linear GBCA, and linear GBCA is avoided today because of the risk of NSF; therefore, it is difficult to plan a prospective comparison study between macrocyclic and linear GBCA in human subjects. Second, the number of times of GBCA administration was explored on medical charts as much as possible, but some patients with long-term follow-up in the GBCA group might have some additional GBCA administration at outside hospitals that were not counted in number of times of GBCA administration. Third, globus pallidus was not included for evaluation in this study. Several articles revealed relatively higher signal on T 1 -weighted image probably due to gadolinium deposition 2, 5, 6 ; however, the signal increase on T 1 -weighted image was much smaller than that of DN. In addition, physiological iron accumulation is frequently seen in the globus pallidus 29 ; therefore, we focused solely the susceptibility change in the DN.
In conclusion, the susceptibility values in DN after serial GBCA administration were significantly higher in comparison with healthy volunteers. This fact was compared with our initial hypothesis that QSM could detect gadolinium deposition at DN after serial GBCA administration.
